期刊文献+

重组血管紧张素转换酶2对高血压小鼠肾脏Nephrin信号及结构损伤的影响 被引量:2

Effects of recombinant angiotensin-converting enzyme 2 on renal Nephrin signaling and structural injury in hypertensive mice
收藏 分享 导出
摘要 目的 探讨高血压状态下肾脏组织足细胞蛋白Nephrin信号改变以及重组血管紧张素转换酶2(ACE2)干预治疗对该信号和肾脏超微结构改变的影响。方法 采用10~11周龄C57/B6小鼠,随机分成3组:正常对照组(n=8);高血压+安慰剂组(n=6);高血压+重组ACE2干预组(n=6)。高血压+安慰剂组和高血压+重组ACE2干预组小鼠每天经微泵给予1.5mg/kg血管紧张素Ⅱ(AngⅡ)制备高血压模型,然后每天分别经腹腔注射给予安慰剂或重组ACE2 2mg/kg治疗,为期2周。用尾套法测定小鼠血压水平。采用Western-blot及硫代巴比妥酸比色法检测小鼠肾脏组织中Nephrin表达和丙二醛含量。用透射电镜技术观测小鼠肾脏超微结构改变。结果 与正常对照组相比,高血压+安慰剂组小鼠血压水平明显升高[(156.2±9.8)比(100.8±9.9)mm Hg,P〈0.01],肾脏组织中Nephrin蛋白表达下调,丙二醛含量增加[Nephrin相对表达:0.48±0.06比1.00±0.08;丙二醛(159.6±12.1)比(55.2±9.0)nmol/g,均P〈0.01],与高血压+安慰剂组相比,高血压+重组ACE2组小鼠血压明显下降[(134.8±8.3)比(156.2±9.8)mm Hg,P〈0.05],肾脏组织Nephrin表达增加,丙二醛含量下降[Nephrin:0.71±0.07比0.48±0.06;丙二醛:(98.5±11.5)比(159.6±12.1)nmol/g,均P〈0.05]。另外,重组ACE2干预明显改善高血压小鼠肾脏功能,并减轻肾脏超微结构损伤,表现为肾小管空泡线粒体结构减少,肾小球基底膜增厚与足突细胞融合现象得到改善。结论 高血压状态下存在肾脏组织中Nephrin信号下调,伴有氧化应激增强和结构损伤明显,而重组ACE2治疗通过改善高血压小鼠肾脏Nephrin表达水平,可促使肾脏氧化应激水平降低与结构损伤减轻,提示ACE2对高血压具有一定的肾脏保护功效。 Objective To investigate the alteration of renal podocyte Nephrin signaling and ultrastructural injury in hypertension state and the effects of recombinant human angiotensin-converting enzyme 2 (rhACE2) on these altera- tions. Methods The 10- or 11-week C57/B6 mice were randomized to three groups, including the normal control group (n= 8 ), the hypertension+ placebo group (n = 6 ) and the hypertension+ rhACE2 treatment group ( n = 6 ). Hypertensive model was established by infusion of angiotensin Ⅱ (Ang Ⅱ ) daily with the dose of 1.5 mg/kg, and the hypertensive mice were then treated with rhACE2 (2 mg/kg per day, intraperitoneal) or placebo for 2 weeks. The systolic blood pressure (SBP) of mice was measured by the tail-cuff method. Nephrin protein and malonyldial- dehyde (MDA) concentrations in mouse kidneys were determined with Western blot and thiobarbituric acid (TBA) reactive substances methods, respectively. In addition, renal ultrastructure was observed via transmission electron microscope. Results Compared with control group, SBP levels were obviously elevated in the AngⅡ-induced hy- pertensive mice [(156.2±9.8) vs (100.8±9.9)mm Hg, P〈0.01], associated with reduced Nephrin protein levelsand enhanced MDA content [Nephrin:0.48±0.06 vs 1.00±0.08 and MDA (159.6±12.1) vs (55.2±9.0)nmol/g, P〈0.01, respectively]. Compared with hypertension+ placebo group, treatment with rhACE2 significantly de- creased SBP levels [(134.8±8.3) vs (156.2±9.8) mm Hg, P〈0.05], and promoted renal Nephrin levels in hy- pertensive mice, along with a marked reduction in MDA contents [Nephrin: 0.71±0.07 vs 0.48±0.06 and MDA (98.5±11.5) vs (159.6±12.1) nmol/g, P〈0.05, respectively]. Finally, treatment with rhACE2 strikingly at- tenuated renal uhrastructure injury in hypertensive mice, characterized with the decrease of vacuolizated mitochondria in renal tubular, and improvement of the thickening glomerular capillary basement membrane and
作者 陈来江 徐颖乐 金海燕 徐冉 张振洲 宋蓓 高平进 钟久昌 CHEN Lai-jiang , XU Ying-le, JIN Hai-yan, XU Ran, ZHANG Zhen-zhou, SONG Bei, GAO Ping-jin, ZHONG Jiu-chang ( State Key Laboratory of Medical Genomics & Shanghai Institute of Hypertension, Ruijin Hospital Affiliated to Shanghai J iaoTong University School of Medicine, Shanghai 200025, China)
出处 《中华高血压杂志》 CAS CSCD 北大核心 2015年第10期952-957,共6页 Chinese Journal of Hypertension
基金 国家重大研究计划资助项目(91339108) 国家自然科学基金项目(81170246 81370362) 国家重点基础研究发展计划(2014CB542300) 上海市卫生局科研课题(201440368)
关键词 高血压 血管紧张素转换酶2 氧化应激 NEPHRIN 肾脏保护 Hypertension Angiotensin-converting enzyme 2 Nephrin Oxidative stress Renoprotection
作者简介 通信作者:钟久昌,E-mail:jiuchangzhong@aliyun.com.
  • 相关文献

参考文献15

  • 1蒋毅弘(综述),钟久昌(审校).血管紧张素转换酶2、氧化应激与高血压[J].中华高血压杂志,2011,19(6):518-520. 被引量:22
  • 2金海燕,陈来江,李春波,徐颖乐,张振洲,林国珍,高平进,钟久昌.A T1受体阻断剂对小鼠海马脑源性神经营养因子信号的影响[J].心血管康复医学杂志,2015,24(2):123-126. 被引量:2
  • 3Yu S. Role of nephrin in podocyte injury induced by angiotensin 1I [J]. J Recept Signal Transduct Res, 2014,29 (1) : 1-5. 被引量:1
  • 4Mdrquez E, Riera M, Pascual J, el: al. Renin-angiotensin system within the diabetic podocyte[J].Am J Physiol Renal Physiol, 2015,308 ( 1 ) : F1-F10. 被引量:1
  • 5Zhong J, Guo D, Chen CB, et al. Prevention of angiotensin H-media- ted renal oxidative stress, inflammation, and fibrosis by angiotensin- converting enzyme 2[J].Hypertension, 2011,57 (2) : 314-322. 被引量:1
  • 6Patel VB, Zhong JC, Fan D, et ~1. Angiotensin-converting en- zyme 2 is a critical determinant of angiotensin II-induced loss of vascular smooth muscle cells and adverse vascular remodeling[J]. Hypertension, 2014,64(1) : 157-164. 被引量:1
  • 7Li X, Chuang PY, D'Agati VD, et al. Nephrin preserves podo- eyte viability and glomerular structure and function in adult kid- neys[J]. J Am Soe Nephrol, 2015, 2 6 (10) : 2361-2377. 被引量:1
  • 8Zhong JC, Basu R, Guo D, et al. Angiotensin-converting enzyme 2 suppresses pathological hypertrophy, myocardial fibrosis, and cardiac dysfunction[J].Circulation, 2010,122(7) : 717-728. 被引量:1
  • 9Baffle D, Soler MJ, Wysocki J. New aspects of the renin-angio-tensin system: angiotensin-converting enzyme 2-a potential target for treatment of hypertension and diabetic nephropathy[J]. Curr Opin Nephrol Hypertens,2008,17(3) :250-257. 被引量:1
  • 10Ye M, Wysocki J, William J, et al. Glomerular localization and expression of angiotensin-converting enzyme 2 and angiotensin- converting enzyme., implications for albuminuria in diabetes[J]. J Am Soc Nephrol,2006,17(ll)..3067-3075. 被引量:1

二级参考文献45

  • 1钟久昌 ,朱鼎良 .血管紧张素转换酶2与高血压[J].高血压杂志,2005,13(11):682-686. 被引量:18
  • 2Briones AM, Touyz RM. Oxidative stress and hypertension: cur rent concepts[J]. Curr Hypertens Rep,2010,12(2) : 135 1-12. 被引量:1
  • 3Lambert DW, Hooper NM, Turner AJ. Angiotensin-converfing enzyme 2 and new insights into the rennin-angiotensm system[J]. Biochemical Pharmacology,2008,75(4) ;781-786. 被引量:1
  • 4GwathmeyTM, Pendergrass KD, Reid SD, et al. Angiotensin (1-7)-angiotensin-converting enzyme 2 attenuates reactive oxygen species formation to angiotensin Ⅱ within the cell nucleus[J]. Hypertension,2010,55(1):166-171. 被引量:1
  • 5Zhong JC, Guo D, Chen CB, el al. Prevention of angiotensin Ⅱ mediated renal oxidative stress, inflammation, and fibrosis by an giotensin converting enzyme [J]. Hypertension, 2011,57(2) 314-322. 被引量:1
  • 6Zhong JC, BasuR, Guo D, etal. Angiotensin converlmg enzyme 2 suppresses pathological hypertrophy, myocardial l'ibrosis, and cardiac dysfunction[J]. Circulation, 2010,122 ( 7 ) : 717-728. 被引量:1
  • 7E1Bekay R, Alvarez M, MonteseirinJ, etal. Oxidative stress is a critical mediator of the angiotensin II signal in human neutro phils: involvement of mitogen activated protein kinase, calei neurin, and the transcription factor NF kappaB[J]. Blood,2003, 102(2):662-671. 被引量:1
  • 8Dworakowski R, Amlkumar N, Zhang M, el al. Redox signaling involving NADPH oxidase derived reactive oxygen species[J]. giochem Soe Trans,2006,34(Pt5):960-964. 被引量:1
  • 9Feng Y, Xia H, Cai Y, et al. Brain selecdve overexpression of human angiolensin-converting enzyme type 2 atlenuates neurogen ic hypertension[J]. Circ Res,2010,106(2) :373-382. 被引量:1
  • 10Xia H, Lazartigues E. Angiotensin converting enzyme 2:central regulator for cardiovascular tunction[J]. Curr Hypertens Rep, 2010,12(3) :170-175. 被引量:1

共引文献25

同被引文献24

  • 1Torres VE, Abebe KZ, Chapman AB, et al. Angiotensin blockade in late autosomaldominant polycystic kidney disease[J]. N Engl J Med, 2014, 371(24): 2267-2276. 被引量:1
  • 2Swaminathan S, Shah SV. Novel inflammatory mechanisms of acceleratedatherosclerosis in kidney disease[J]. Kidney Int, 2011,80(5): 453-463. 被引量:1
  • 3Chen LJ, Xu YL, Song B, et al. Angiotensin-converting enzyme 2 amelioratesrenal fibrosis by blocking the activation of mTOR/ERK signaling in apolipoproteine-deficient mice[J]. Peptides, 2016,79: 49-57. 被引量:1
  • 4Rofe MT, Levi R, Hertzberg-Bigelman E, et al. Cardiac hypertrophy and cardiac celldeath in chronic kidney disease[J]. Isr Med Assoc J, 2015, 17(12): 744-749. 被引量:1
  • 5Ning WB. Hu GY, Peng ZZ, et al. Fluorofenidone inhibits Ang II-inducedapoptosis of renal tubular cells through blockage of the Fas/FasL pathway[J]. IntImmunopharmacol, 2011,11(9): 1327-1332. 被引量:1
  • 6Patel VB, Zhong JC, Fan D, et al. Angiotensin-converting enzyme 2 is a criticaldeterminant of angiotensin II-induced loss of vascular smooth muscle cells andadverse vascular remodeling{J]. Hypertension, 2014, 64(1): 157-164. 被引量:1
  • 7Zhong J, Basu R, Guo D, et al. Angiotensin-converting enzyme 2 suppressespathological hypertrophy, myocardial fibrosis, and cardiac dysfunction[J]. Circulation,2010,122(7): 717-728. 被引量:1
  • 8Jin HY, Chen LJ, Zhang ZZ, et al. Deletion of angiotensin-converting enzyme 2exacerbates renal inflammation and injury in apolipoprotein E-deficient mice throughmodulation of the nephrin and TNF-alpha-TNFRSFlA signaIing[J], J Transl Med,2015,13(1): 255. 被引量:1
  • 9Zhong J, Guo D, Chen CB, et al. Prevention of angiotensin II-mediated renaloxidative stress, inflammation, and fibrosis by angiotensin-converting enzyme 2[J],Hypertension, 2011, 57(2): 314-322. 被引量:1
  • 10Sahara M, Ikutomi M, Morita T, et al. Deletion of angiotensin-converting enzyme2 promotes the development of atherosclerosis and arterial neointima formation[J],Cardiovasc Res, 2014, 101(2): 236-246. 被引量:1

引证文献2

二级引证文献2

投稿分析

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部 意见反馈